NICE recommends MSD's pembrolizumab to treat melanoma
The UK NICE has recommended pembrolizumab (Keytruda) manufactured by MSD to treat melanoma, the most common form of skin cancer.
Stay updated with breaking news from Blake Dark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The UK NICE has recommended pembrolizumab (Keytruda) manufactured by MSD to treat melanoma, the most common form of skin cancer.
NNHS patients in England will have early access to potentially life-saving and cutting-edge treatments thanks to a new fund which has been launched today.
The most promising medicines will be fast-tracked to NHS patients through Innovative Medicines Fund
Two new antibiotic drugs are set to become available to NHS patients with severe drug-resistant infections in England, as part of a UK initiative aiming
A deal is being struck to make them freely available to patients in England at an affordable cost to the NHS.